Rest Of World

Amid a structural shift towards Asia, Insilico Medicine's IPO in December was a significant moment for the exchange, while French biotech TheraVectys is understood to be considering a listing.

US president Donald Trump has issued 15% tariffs on every country exporting to the US after his so-called reciprocal tariffs were ruled illegal by the US Supreme Court.

If the deal is finalised, a combination of the US and UK global asset managers will control almost $2.5 trillion of assets under management; they both have offices across Apac.

Kevin Warsh, the youngest-ever Federal Reserve governor, needs to be approved by the Senate committee on banking.

The UK pharmaceutical giant has announced a landmark $15bn China investment during the UK prime minister’s visit, marking its largest expansion yet to boost manufacturing, R&D and biotech collaboration.

India and the EU have signed a free trade agreement after years of negotiating; over 90% of goods are set to move tariff free.

Allied Gold owns several large gold mines in Africa with the Canadian firm describing the all-cash offer as "friendly"; its annual gold output is expected to increase to 25 tonnes by 2029.

Coller Capital is a global secondaries firm with around $50bn in AUM and six Apac offices. EQT's CEO believes Coller's business can double in size in under four years; the PE giant is paying up to $3.7bn. In Japan, EQT has launched a bid for Mamezo.

The Standard Chartered supported issuance follows the Qatar National Bank’s $500m offering in November.